|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Collaboration revenue | ||
| Operating expenses: | ||
| Research and development | ||
| General and administrative | ||
| Total operating expense | ||
| Loss from operations | ||
| Other income (expense), net: | ||
| Interest income | ||
| Interest expense | ||
| Loss on early extinguishment of debt | ||
| Change in fair value of preferred stock purchase right liability | ||
| Change in fair value of preferred stock warrant liability | ||
| Total other income (expense), net | ||
| Loss from continuing operations | ||
| Net loss | ||
| Other comprehensive loss: | ||
| Unrealized loss on marketable securities, net | ||
| Comprehensive loss | ||
| Net loss per share, basic and diluted: | ||
| Continuing operations | ||
| Net loss per share, basic | ||
| Weighted average shares outstanding, basic and diluted | ||
| Net loss per share, diluted | ||
| Weighted average shares outstanding, basic | ||
| Weighted average shares outstanding, diluted |
Loading...
